Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reoxygenation in the RIF-1 tumor after chemotherapy.

M J Dorie1, R F Kallman

  • 1Department of Radiation Oncology, Stanford University Medical Center, CA 94305.

International Journal of Radiation Oncology, Biology, Physics
|January 1, 1992
PubMed
Summary

Chemotherapy affects tumor oxygen levels differently. Cyclophosphamide increases hypoxic cells long-term, impacting cancer treatment effectiveness and drug selection timing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.

Cancer research·2001
Same author

DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.

Neoplasia (New York, N.Y.)·2000
Same author

Oxygen tension measurements of tumors growing in mice.

International journal of radiation oncology, biology, physics·1999
Same author

Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.

Radiation oncology investigations·1999
Same author

1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxins with antitumor activity.

Anti-cancer drug design·1998
Same author

Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.

Cancer research·1997

Area of Science:

  • Oncology
  • Cancer Biology
  • Radiation Oncology

Background:

  • Tumor hypoxia is a significant factor in radioresistance and chemotherapy resistance.
  • Understanding how different chemotherapy agents affect tumor oxygenation is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate the impact of bleomycin, cisplatin, cyclophosphamide, and mitomycin C on the hypoxic fraction of RIF-1 tumors.
  • To determine the temporal changes in tumor reoxygenation following treatment with these agents.

Main Methods:

  • Utilized the paired survival curve method to assess the hypoxic fraction in RIF-1 tumors.
  • Tumors were irradiated under aerobic and artificial hypoxic conditions post-drug administration.
  • Monitored hypoxic fraction for 24 hours after treatment with various chemotherapeutic agents.

Main Results:

  • Bleomycin and mitomycin C transiently increased the hypoxic fraction, with levels returning to baseline within 1-2 hours.
  • Cisplatin did not significantly alter the hypoxic fraction compared to baseline levels.
  • Cyclophosphamide caused a sustained elevation in the hypoxic fraction, persisting throughout the 24-hour observation period.

Conclusions:

  • Different chemotherapy drugs have distinct effects on tumor reoxygenation kinetics.
  • The timing of assessing drug efficacy against hypoxic versus aerobic cells is critical and can be influenced by the specific chemotherapeutic agent used.

Related Experiment Videos